DRUG · NASDAQ · Biotechnology

Bright Minds Biosciences (DRUG)

Develops selective serotonin agonists for epilepsy, PWS, and neuropsychiatric disorders.

$57.42
vs last close−3.25 (−5.35%)

Something off on this page? Send us feedback.

Next report
Dec 22, 26
estimated · in 90 days
EPS estimate
−$1.07
Revenue estimate
Fiscal quarter
Q1 FY27

EPSReportedEstimate

Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Dec '26
Reported$0.01−$0.29−$0.53−$0.41−$0.70−$0.80−$0.17Pending
Estimate−$0.23−$0.39−$0.59−$0.56−$0.98−$1.06−$1.22−$1.07
Surprise+104.3%+25.6%+10.2%+27.1%+28.6%+24.5%+86.1%

RevenueReportedEstimate

Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Dec '26
ReportedPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Sep 2027−$2.79
Jun 2027−$2.33
Mar 2027−$2.04
Dec 2026−$1.07
Sep 2026−$1.49
Aug 2026−$1.22−$0.17+86.1%
May 2026−$1.06−$0.80+24.5%
Feb 2026−$0.98−$0.70+28.6%
Dec 2025−$0.56−$0.41+27.1%
Aug 2025
May 2025
Feb 2025
Dec 2024
Aug 2024
May 2024
Feb 2024
Dec 2023
Aug 2023
May 2023
Feb 2023
Dec 2022
Aug 2022
May 2022
Feb 2022
Dec 2021
Jul 2021
Mar 2021
Jun 2021
Sep 2020
Jun 2020
Mar 2020
Dec 2019

The latest year is open to everyone — the 23 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Sep 2027−$2.79$0
Jun 2027−$2.33$0
Mar 2027−$2.04$0
Dec 22, 2026−$1.07$0
Sep 2026−$1.49$0
Aug 17, 2026−$1.22−$0.17+86.1%+4.0%
May 20, 2026−$1.06−$0.80+24.5%+11.1%
Feb 12, 2026−$0.98−$0.70+28.6%+3.4%
Dec 23, 2025−$0.56−$0.41+27.1%+1.5%
Aug 14, 2025
May 15, 2025
Feb 13, 2025
Dec 30, 2024
Aug 14, 2024
May 15, 2024
Feb 12, 2024
Dec 29, 2023
Aug 14, 2023
May 15, 2023
Feb 7, 2023
Dec 29, 2022
Aug 12, 2022
May 16, 2022
Feb 14, 2022
Dec 29, 2021
Jul 17, 2021
Mar 31, 2021
Jun 17, 2021
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019

The latest year is open to everyone — the 23 quarters behind it read with an account.